In ovarian epithelial neoplasms, the overexpression of LDLR is associated with cisplatin resistance, and the knockdown of LDLR reduces tumor growth by suppressing autophagy associated with the PI3K/AKT/mTOR pathway [38]. Here, AKT1 is linked to neoplasm.